US$ 23.56
glp-1/gip dual agonist Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care Mechanisms of action of GLP-1
Description
Sanofi SA

Whats more, over a dozen potential new GLP-1 RAs are being developed [archived link]
They looked at outcomes that occurred with continued GLP-1 use into the first trimester, comparing them to non-continuation of the medicines

However, the methods required to confirm specific receptors are limited, as antibodies need to be able to distinguish between cleaved and non-cleaved peptides, which differ by only two amino acids at the N-terminal end

The studies included different populations of patients with DM, including both patients nave of insulin as well as patients already receiving insulin
